S-Space

Browse

Author

Showing results 1 to 2 of 2

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2021-03	Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer Perets, R.; Bar, J.; Rasco, D. W.; Ahn, M-J; Yoh, K.; Kim, D-W; Nagrial, A.; Satouchi, M.; Lee, D. H.; Spigel, D. R.; Kotasek, D.; Gutierrez, M.; Niu, J.; Siddiqi, S.; Li, X.; Cyrus, J.; Chackerian, A.; Chain, A.; Altura, R. A.; Cho, B. C. Annals of Oncology, Vol.32 No.3, pp.395-403	DOI
2022-02	First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer Niu, J.; Maurice-Dror, C.; Lee, D. H.; Kim, D. -W.; Nagrial, A.; Voskoboynik, M.; Chung, H. C.; Mileham, K.; Vaishampayan, U.; Rasco, D.; Golan, T.; Bauer, T. M.; Jimeno, A.; Chung, V.; Chartash, E.; Lala, M.; Chen, Q.; Healy, J. A.; Ahn, M. -J. Annals of Oncology, Vol.33 No.2, pp.169-180	DOI